Clinical Trial Update: Efficacy of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating topical mesenchymal stromal cell secretome for ocular surface disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Corneal Epithelial Disorders
• Persistent Epithelial Defect

Drugs mentioned

• Topical mesenchymal stromal cell secretome

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Persistent Corneal Epithelial Defect, Corneal Epithelial Disorders | Phase 2 | Status: RECRUITING